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 Abstract 
 Autoimmune polyendocrinopathy-candidiasis-ectodermal 
dystrophy syndrome (APECED) or autoimmune poly-
endocrine syndrome type 1 (APS-1) is a rare autosomal 
recessive disease caused by mutations of the AutoImmune 
REgulator ( AIRE ) gene, an important mediator of tolerance 
to self-antigens. It is characterized by two out of three major 
components: chronic mucocutaneous candidiasis, hypopara-
thyroidism and Addison ’ s disease. We present an 11-year-
old girl suffering from recurrent episodes of mucocutaneous 
candidiasis and onychomycosis from 1 to 6  years of age, and 
transient alopecia at the age of 4  years. Hypoparathyroidism 
and dental enamel hypoplasia were diagnosed at 8  years. 
Autoantibodies to thyroid and adrenal glands were not 
detected and all other endocrine functions have remained 
normal. Genetic analysis revealed that the patient was 
homozygous for the mutation T16M in exon 1 of the  AIRE 
gene (p.T16M, c.47C > T). This is the fi rst APECED case 
reported for carrying this mutation in homozygous form. 
Parents were third cousins and heterozygous carriers of this 
mutation. 
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 Introduction 
 Autoimmune polyendocrinopathy-candidiasis-ectodermal dys-
tro phy syndrome (APECED) or autoimmune polyen docrine 
syndrome type 1 (APS-1) is a rare autosomal recessive dis-
ease  (1 – 3) generally seen in infants and children that is caused 
by mutations of the AutoImmune REgulator ( AIRE ) gene on 
chromosome 21q22.3  (4, 5) . It is characterized by the presence 
of at least two of three components: chronic mucocutaneous 
candidiasis, hypoparathyroidism and Addison ’ s disease, but 
can also include other clinical manifestations, such as auto-
immune thyroid disease, type 1 diabetes mellitus, alopecia, 
vitiligo, ectodermal dystrophy, malabsorption and pernicious 
anemia  (6) . 
 The aim of this report is to present the fi rst genetically 
confi rmed case of APECED in Greece (the fourth worldwide 
according to PubMed), in which the syndrome was found to 
be due to homozygosity for a very rare mutation of  AIRE , 
p.T16M. 
 Case report 
 The patient, now an 11-year-old girl, was fi rst referred to the 
Infectious Diseases Clinic of our Department at the age of 
3  years due to frequent relapses of mucocutaneous candidia-
sis. She was the second child of reportedly non-consanguine-
ous parents from the South-eastern Aegean island of Rhodes, 
Greece. Clinical examination on admission revealed candidi-
asis of the oral cavity, axillary folds, and nails of both hands. 
Mucocutaneous candidiasis had appeared at the age of 1  year 
and the patient kept relapsing until the age of six. During the 
fi rst 5  years the frequency of the episodes was once a month, 
whereas during the 6th year they occurred every 3  months. 
Multiple cultures from the oral cavity grew  Candida albicans . 
Candidiasis of the axillary folds lasted for 1  month and ony-
chomycosis for 6  months. At the age of 4  years the patient also 
presented with transient alopecia and hair-thinning that lasted 
for about 4  months. Each relapse of mucocutaneous candidi-
asis was effectively treated with oral itraconazole solution 
(5  mg/kg/day). The patient was followed up at the Infectious 
Diseases Clinic of our Department of Pediatrics annually. 
 Immunological tests at the age of 3  years, including immu-
noglobulins and cell-mediated immune response, were nor-
mal. Three years later, follow-up revealed relatively low 
levels of IgM, increased levels of C3 and low rhodamine oxi-
dation (oxidative burst) of phagocytes. Antinuclear antibodies 
(ANA) and anti-neutrophil cytoplasmic (ANCA) antibodies 
were negative. After the age of 6  years, repetitive cultures 
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from pharynx and oral cavity during the annual visits were 
negative, while biochemical tests were all normal. 
 During a follow-up visit at the age of 8  years, laboratory 
tests revealed hypoparathyroidism suggested by low serum 
calcium (Ca) and high phosphate (P) levels (7.1 and 8.9  mg/dL, 
respectively), and intact parathormone 3  pg/mL (normal levels 
 > 7  pg/mL). As the patient fulfi lled two major diagnostic cri-
teria for the diagnosis of APECED, additional investigations 
were performed in order to exclude other conditions possibly 
associated with this syndrome. Serum levels of cortisol before 
and after administration of adrenocorticotropic hormone 
(ACTH) were normal. Autoantibodies against several organs 
[ANA, antithyroid antibodies (ATA), anti-DNA, smooth mus-
cle antibodies (SMA), parietal cells antibodies (PCA), liver/
kidney/microsomal antibodies (LKM), islet cell antibodies 
(ICA)] were negative. A dental exam at this age revealed den-
tal enamel hypoplasia. 
 Hypoparathyroidism was initially treated with calcitriol 
and calcium carbonate. With this treatment, calcium levels 
were completely restored. Later, low phosphorus diet and 
the non-calcium based binder sevelamer were added. During 
follow-up, renal function remained normal. In addition, there 
was no calciuria or proteinuria (evidenced as urinary excre-
tion of albumin and  β 2 microglobulin), and there was no evi-
dence of nephrocalcinosis in renal ultrasound. 
 Genetic analysis 
 The diagnosis of APECED was genetically confi rmed at the 
age of 10  years, in the Molecular Diagnostic Laboratory, 
Geneva University Hospitals. Polymerase chain reac-
tion amplifi cation from leukocyte DNA followed by DNA 
sequencing of the entire  AIRE coding region (primer 
sequences available on request) revealed that the patient was 
homozygous for the mutation T16M in exon 1 of the  AIRE 
gene (p.T16M, c.47C > T). Both parents were found to be 
heterozygous carriers of the mutation. Despite their insistent 
denial of consanguinity, a thorough investigation revealed 
that the parents were third cousins. 
 The patient ’ s 12-year-old brother was asymptomatic with-
out any abnormal signs on physical examination. His serum 
levels of Ca and P were normal. According to the wish of his 
parents, no further investigations were performed. 
 Discussion 
 APECED is a rare disease, but is more frequent in certain 
populations. Its prevalence is estimated to be 1:80,000 in 
Norway, 1:30,000 in Ireland, 1:25,000 in Finland, 1:14,000 
in Sardinia, Italy and 1:9000 among Iranian Jews  (7) . The 
largest reported series was conducted in Finland in 2006 and 
included 91 patients  (2) . 
 APECED has three major clinical components: chronic 
mucocutaneous candidiasis, hypoparathyroidism, and Add-
ison ’ s disease. The presence of at least two of them is required 
for the clinical diagnosis  (7) . Although this diagnostic crite-
rion is valid, it leaves many patients unrecognized. Recently, 
Meloni et al. proposed the presence of autoantibodies against 
interferon  – ω and  α 2 to diagnose APECED in patients with just one of the APECED triad  (7, 8) . Due to its high sensitivity 
and specifi city this test has been proposed as a simpler diag-
nostic option than detecting  AIRE mutations  (8) . 
 APECED is caused by mutations of the  AIRE gene, which 
consists of 14 exons and is located on chromosome 21q22.3 
 (2) . To date, about 60 mutations have been reported, and com-
prise nonsense and missense mutations, deletions, and small 
insertions  (9) . The mutations R257X (exon 6), c.967-979-
del13 (exon 8), R139X (exon 3), and Y85C (exon 2) appear 
to be more common  (10) . The most common  “ Finnish ” muta-
tion R257X results in a premature stop codon in the SAND 
domain of AIRE protein  (2, 10) . The mutation of our patient ’ s 
 AIRE T16M is very rare and, to the best of our knowledge, 
has been reported only in three patients (one Russian and two 
Slovenians) to date (Table  1 ). All four patients suffered from 
mucocutaneous candidiasis and hypoparathyroidism, whereas 
three of the three patients with data available suffered from 
ectodermal dystrophy. By comparison, only one patient each 
suffered from hypothyroidism or Addison ’ s disease. 
 Our patient is the fi rst known patient homozygous for this 
mutation, confi rming its identity as a classic APECED muta-
tion and adding APECED to the list of very rare recessive 
disorders to be identifi ed in consanguineous couples (the prob-
ability of third cousins to share a specifi c allele is 1/128). The 
denial of consanguinity by the couple underlines the diffi culties 
for individuals and professionals alike to develop accurate and 
comprehensive family histories. It will be interesting to search 
for further cases of patients with T16M from the same region. 
 The AIRE protein contains several structural motifs com-
mon to nuclear proteins and transcription factors  (11) .  AIRE 
gene is predominantly expressed within the thymus in a spe-
cialized subset of thymic stromal cells known as medullary 
thymic epithelial cells and controls ectopic expression of 
tissue-restricted antigens  (12) .  AIRE -mediated regulation of 
 Table 1  Reported cases with  AIRE gene mutation T16M. 
Patient  # 1  # 2  # 3 Present
Year of publication 2001 2005 2005 2011
(Ref)  (4)  (5)  (5) 
Age at fi rst clinical 
manifestations
NA 3.7 years 5.5 years 1 year
Ethnicity Russian Slovenian Slovenian Greek
Sex (M/F) NA M F F
AIRE mutation R257X/
T16M
R257X/
T16M
R257X/
T16M
T16M/
T16M
Clinical characteristics
  MC  +  +  +  + 
  HP  +  +  +  + 
  AD  +  –  –  – 
  ED NA  +  +  + 
  HT  +  –  –  – 
  MA NA  +  –  – 
  A NA  +  –  + 
 A, alopecia; AD, Addison ’ s disease; ED, ectodermal dystrophy; HP, 
hypoparathyroidism; HT, hypothyroidism; MA, malabsorption; MC, 
mucocutaneous candidiasis; NA, not available. 
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diverse self-antigens in the thymus serves as a paradigm for 
the importance of promiscuous gene expression in the pre-
vention of autoimmune disease  (11) . 
 Our immunological fi ndings of constantly low levels of 
IgM, increased levels of C3 and low oxidative bursts of phago-
cytes appear to fi t in the general immunological scenario of 
APECED, in which a number of different disturbances of 
immune functions have been found, such as complement dys-
function, immunoglobulin defi ciencies and innate immune 
response disturbances (e.g., impaired dendritic cell matura-
tion, but not impaired pattern recognition receptors)  (13, 14) . 
 A high clinical suspicion should be maintained for timely 
detection of other autoimmune disorders in patients with 
APECED and their close relatives, especially siblings. Reg-
ular follow-up is very important for the prevention of serious 
sequelae of the disease. 
 As this is the fi rst genetically confi rmed case in Greece, it 
is important to note that the clinical and genetic fi ndings are 
consistent with most cases of APECED reported in the litera-
ture. This similarity exists despite the fact that our patient is 
only the fourth found having AIRE T16M, and the fi rst to be 
homozygous. Close follow-up of endocrine and renal func-
tion is warranted in such a rare case. 
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